Please join CDPH tomorrow from 9:00AM - 10:30AM for the weekly COVID-19 and Monkeypox (MPX) Webinar for Providers. CDPH subject matter experts will provide updates and answer questions on the topics of COVID-19 Vaccine and Therapeutics, and MPX Vaccine and Therapeutics. Please ensure someone from your staff attends this important session.
Tomorrow, Friday, December 2 from 9:00 AM-10:30 AM
Register here!
Q: When will COVID-19 bivalent vaccines be authorized for infants and toddlers ages 6 months – 5 years?
A: The following information is subject to change: CDPH anticipates that the FDA will authorize, and the CDC will recommend, a Moderna bivalent booster for infants/toddlers ages 6 months – 5 years and a Pfizer bivalent third dose (included as part of the Pfizer 3- dose primary series) for infants/toddlers 6 months – 4 years in early to mid-December. For further information, please see the CDPH COVID-19 Call Center Communication and the CDC Fall Vaccination Operational Planning Guide.
For more answers to your questions, please review the California COVID-19 Vaccine Provider FAQs, updated today, with answers to common questions.
COVID-19 Vaccine Quality Assurance Training for Providers Canceled
The COVID-19 Vaccine Quality Assurance Training for Providers on Monday, December 5, 2022, has been canceled. The training series will resume on Monday, December 19, 2022. If you have not done so already, please register for future sessions here.
Provider COVID-19 Call Center Closed December 6, 2022
The Provider COVID-19 Call Center will be closed on Tuesday, December 6, 2022, due to an all-staff meeting. It will open again on Wednesday, December 7, 2022.
